Related Experiment Video

Updated: Jan 4, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

402

Telehealth spirometry for children with cystic fibrosis

Karla Logie1, Liam Welsh2, Sarath C Ranganathan1

  • 1Respiratory Medicine, Royal Childrens Hospital Melbourne, Parkville, Victoria, Australia.

Archives of Disease in Childhood
|November 8, 2019
PubMed

Insights

Telehealth spirometry is feasible for children with cystic fibrosis (CF) in regional areas. This remote monitoring approach supports CF care during home admissions and outpatient visits, saving significant travel time.

Area of Science:

  • Pediatric Pulmonology
  • Digital Health
  • Respiratory Medicine

Background:

  • Children with cystic fibrosis (CF) often require regular spirometry.
  • Access to specialized respiratory care can be challenging for children in regional settings.
  • Traditional spirometry necessitates frequent hospital visits, posing logistical and time burdens.

Purpose of the Study:

  • To evaluate the feasibility of telehealth spirometry for pediatric patients with CF living in regional areas.
  • To assess the effectiveness of remote spirometry in supporting ongoing CF care.
  • To determine the impact of telehealth spirometry on reducing patient travel burden.

Main Methods:

  • A feasibility study involving children aged 7-17 years with CF.
  • Home-based spirometry assessments using SpiroUSB devices provided to families.
  • Data transmission from home to a central pediatric hospital for analysis.
  • Adherence to American Thoracic Society/European Respiratory Society spirometry criteria.

Main Results:

  • High success rate (93%) in telehealth spirometry sessions.
  • Successful implementation in children residing a median of 238 km from the hospital.
  • Significant travel time savings averaging 5 hours and 34 minutes per hospital visit.
  • Feasibility demonstrated across various home monitoring scenarios.

Conclusions:

  • Home-based telehealth spirometry is a viable option for children with CF in remote locations.
  • This technology can effectively support cystic fibrosis care teams during home admissions and outpatient monitoring.
  • Telehealth spirometry enhances patient access to care and reduces the burden of travel for regional families.
Abstract

Keywords:
cystic fibrosismonitoringtechnology

More Related Videos

Conducting Respiratory Oscillometry in an Outpatient Setting14:49

Conducting Respiratory Oscillometry in an Outpatient Setting

Published on: April 8, 2022

8.2K
Methodology for Sputum Induction and Laboratory Processing13:28

Methodology for Sputum Induction and Laboratory Processing

Published on: December 17, 2017

28.5K

Related Concept Videos

Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
681
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
422
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.0K
Chest Physiotherapy01:24

Chest Physiotherapy

Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
1.4K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
683
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.0K